Correlation Between Pluri and Iovance Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Pluri and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pluri and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pluri Inc and Iovance Biotherapeutics, you can compare the effects of market volatilities on Pluri and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pluri with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pluri and Iovance Biotherapeutics.

Diversification Opportunities for Pluri and Iovance Biotherapeutics

0.08

Correlation Coefficient

Pluri  Iovance Biotherapeutics

Significant diversification

The 3 months correlation between Pluri and Iovance is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Pluri Inc and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and Pluri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pluri Inc are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of Pluri i.e., Pluri and Iovance Biotherapeutics go up and down completely randomly.

Pair Corralation between Pluri and Iovance Biotherapeutics

Given the investment horizon of 90 days Pluri Inc is expected to generate 0.53 times more return on investment than Iovance Biotherapeutics. However, Pluri Inc is 1.89 times less risky than Iovance Biotherapeutics. It trades about 0.05 of its potential returns per unit of risk. Iovance Biotherapeutics is currently generating about 0.01 per unit of risk. If you would invest  475.00  in Pluri Inc on May 5, 2025 and sell it today you would earn a total of  41.00  from holding Pluri Inc or generate 8.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pluri Inc  vs.  Iovance Biotherapeutics

Pluri Inc

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pluri Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile basic indicators, Pluri reported solid returns over the last few months and may actually be approaching a breakup point.

Iovance Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Iovance Biotherapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pluri and Iovance Biotherapeutics

The main advantage of trading using opposite Pluri and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pluri position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.

The idea behind Pluri Inc and Iovance Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.